Beone Medicines LTD. (BEIGF) — 10-Q Filings

10-Q Filings (6)

• BeOne Medicines Swings to Profit on Robust 41% Revenue Growth — Nov 6, 2025 Risk: medium
  BeOne Medicines Ltd. (BEIGF) reported a significant turnaround for the three and nine months ended September 30, 2025. Total revenues surged to $1,412,284 thous
• BeOne Medicines Soars on Strong Q2 Product Sales, Collaboration Growth — Aug 6, 2025 Risk: medium
  BeOne Medicines Ltd. (BEIGF) reported a significant increase in product revenue for the three months ended June 30, 2025, reaching $456 million, up from $380 mi
• BeiGene, Ltd. Files Q1 2025 10-Q — May 7, 2025 Risk: medium
  BeiGene, Ltd. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 202
• BeiGene, Ltd. Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  BeiGene, Ltd. filed its 10-Q for the period ending September 30, 2024. The company's fiscal year ends on December 31st. The filing includes financial data for t
• BeiGene, Ltd. Files 10-Q for Q2 2024 — Aug 7, 2024 Risk: medium
  BeiGene, Ltd. filed its 10-Q for the period ending June 30, 2024. The company, operating in the pharmaceutical preparations sector, reported financial results f
• BeiGene, Ltd. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk:
  BeiGene, Ltd. (BEIGF) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. BeiGene, Ltd. filed a 10-Q report for the quarterly period ended March 31, 20

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX